RxDoctor Payments Data

Gina Gunther, APRN

Family · Marion, ILNPI 1942206438

Payments from drug & device makers

$405in general payments, 2019–2025

Across 25 payments — averaging $16.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$99
  • GSK$82
  • Novo Nordisk$76
  • Lilly USA, LLC$70
  • Abbott$22
  • Dexcom, Inc.$15
  • plus $41 from 3 others

What the payments were for

  • Food & beverage$405100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$405 in reported general payments places this provider in the 55th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$1,760
Medicare patients
66
Services billed
92

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban99$86,654
Trelegy ElliptaFluticasone/Umeclidin/Vilanter99$63,877
TrulicityDulaglutide60$63,181
JardianceEmpagliflozin69$47,991
OzempicSemaglutide33$31,735
TradjentaLinagliptin32$25,149
LinzessLinaclotide22$23,094
Victoza 3-PakLiraglutide14$14,066
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog35$13,132
XareltoRivaroxaban12$11,087
ArexvyRsvpref3 Antigen/As01e/Pf37$9,750
Spiriva RespimatTiotropium Bromide13$8,767
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$8,687
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$8,079
FarxigaDapagliflozin Propanediol12$6,542

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Arexvy, Anoro Ellipta, Incruse Ellipta$82$85,527165 claims
Lilly USA, LLCTrulicity$70$63,18160 claims
Novo NordiskOzempic$76$31,73533 claims
AbbVieLinzess$99$23,09422 claims
AstraZenecaFarxiga, Symbicort$13$11,46524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,941 family providers in Illinois.

Other family in Marion

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →